文献速递免疫规划妇幼与学校卫生

孕期推荐疫苗接种相关不良事件的系统综述概览

Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews.
PubMed 文献 · Vaccine · 2020-09-21

多数系统综述未发现明确风险,部分发现流感疫苗对死产、新生儿死亡、早产、低出生体重及Tdap对早产和小于胎龄儿有保护作用;乙肝、脑膜炎球菌和黄热病疫苗证据不确定。

要点

  • 孕期推荐疫苗(流感、Tdap)未发现明确不良妊娠结局风险。
  • 部分系统综述提示流感疫苗和Tdap疫苗可能降低早产等不良结局。
  • 乙肝、脑膜炎球菌和黄热病疫苗的孕期安全性证据尚不充分。

核心结论

  • 未发现任何疫苗与任何结局存在明确风险,但所有结局和疫苗均需更高质量证据。

研究设计与样本

  • 系统综述概览(OoSRs),检索Cochrane Library、MEDLINE和EMBASE 2010年至2019年4月发表的系统综述。

主要发现

  • 死产和早产是最常报告结局,分别由15篇和13篇系统综述报告。
  • 8篇系统综述发现流感疫苗对死产、新生儿死亡、早产、低出生体重的保护作用,或Tdap对早产和小于胎龄儿的保护作用。
  • 1篇系统综述发现Tdap与绒毛膜羊膜炎可能相关。
  • 乙肝、脑膜炎球菌和黄热病疫苗的系统综述结论不确定。

关键数值与推荐

  • 流感疫苗系统综述11篇,Tdap疫苗4篇,乙肝、黄热病、脑膜炎球菌疫苗各1篇。
  • 大多数系统综述未发现疫苗与不良结局的关联。

临床怎么用

  • 孕期接种流感疫苗和Tdap疫苗的获益-风险比仍为正向,可支持推荐接种。
  • 对乙肝、脑膜炎球菌和黄热病疫苗的孕期安全性应个体化评估,现有证据不充分。

局限性

  • 支持疫苗安全性的证据主要基于观察性数据。
  • 需要更多充分报告母胎结局的随机对照试验和更大规模高质量观察性研究。
  • 部分系统综述方法学质量极低(6篇)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Maternal immunization is aimed at reducing morbidity and mortality in pregnant women and their newborns. Updated evidence synthesis of maternal-fetal outcomes is constantly needed to ensure that the risk-benefit of vaccination during pregnancy remains positive. METHODS: An overview of systematic reviews (OoSRs) was performed. We searched The Cochrane Library, MEDLINE and EMBASE for SRs including recommended vaccines for maternal immunization reporting the following: abortion, stillbirth, chorioamnionitis, congenital anomalies, microcephaly, neonatal death, neonatal infection, preterm birth (PTB), low birth weight (LBW), maternal death and small for gestational age (SGA) from 2010 to April 2019. Quality and overlap of SRs was assessed. RESULTS: Seventeen SRs were identified, eight of them included meta-analysis; quality was high in three SRs, moderate in six SRs, low in two SRs, and critically low in six SRs. Stillbirth and PTB were the most frequently reported outcomes by 15 and 13 SRs, respectively, followed by abortion (9 SRs), congenital anomalies (9 SRs), SGA (8 SRs), neonatal death (8 SRs), LBW (4 SRs), chorioamnionitis (3 SRs), maternal death (1 SR). SRs included mainly observational evidence for influenza and Tdap vaccines (11 SRs and 4 SRs, respectively); limited evidence was found for hepatitis (1 SR), yellow fever (1 SR), and meningococcal (1 SR) vaccines. Most of the SRs found no effect. Eight SRs found benefit/protection of influenza vaccine (for stillbirth, neonatal death, preterm birth, LBW), or Tdap vaccine (for preterm birth and SGA); one found a probable risk (chorioamnionitis/Tdap). The SRs for Hepatitis B, meningococcal and yellow fever vaccines were inconclusive. CONCLUSIONS: Definite risks were not identified for any vaccine and outcome; however better evidence is needed for all outcomes and vaccines. The available evidence in the SRs to support vaccine safety was based mainly on observational data. More RCTs with adequate reporting of maternal-fetal outcomes and larger high-quality observational studies are needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Macias Saint-Gerons D, Solà Arnau I, De Mucio B, et al. Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews. Vaccine. 2020. PMID: 32972737. doi:10.1016/j.vaccine.2020.07.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。